Dynamic Contrast-Enhanced MRI for Diagnosing Osteoradionecrosis
1,400
about 10 years
18+
1 site in TX
What this study is about
This trial is testing if dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can help doctors diagnose osteoradionecrosis in people with head and neck cancer who are receiving radiation therapy. DCE-MRI may assist doctors to predict osteoradionecrosis in patients with head and neck cancer undergoing radiation therapy.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Questionnaire Administration
- 2.Undergo Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: DCE-MRI Derived Parameters Following External Beam Radiation Therapy (EBRT) and Subsequent Development of Osteoradionecrosis (ORN)
Secondary: Dose-Response Relationships Between DCE-MRI Derived Imaging Biomarkers and Subsequent Development of Osteoradionecrosis (ORN)
imaging
Oncology